Today's Top 20 Gastroenterology and Endoscopy Stories
  • BCBS Massachusetts to restrict anesthesia coverage for certain GI procedures

    Beginning Jan. 1, Blue Cross Blue Shield Massachusetts will no longer cover the use of monitored anesthesia for certain gastrointestinal patients undergoing endoscopic, bronchoscopic, or interventional pain procedures. 
  • USPI doubles down on GI

    United Surgical Partners International, Dallas-based Tenet Healthcare's ASC chain, has seen strong growth in the gastroenterology care sector the last two quarters, according to the company's second- and third-quarter earnings calls. 
  • 5 things to know about Allied Digestive Health

    Here are five things to know about gastroenterology-focused multispecialty group Allied Digestive Health:
  • Dr. Mohammad Fahad Ali named GI chief at Oswego Health

    Mohammad Fahad Ali, MD, director of endoscopy at Oswego (N.Y.) Health, has been appointed chief of gastroenterology and hepatology and director of the Center for Gastroenterology & Metabolic Diseases at Oswego, according to a Nov. 9 report from the Central New York Business Journal. 
  • 4 notable gastroenterology practice acquisitions in 2023

    As gastroenterology management organizations have continued to grow in 2023, Provident has broken down four major acquisitions that occurred in 2023 in its third quarter "Mergers and Acquisitions Update" report.
  • 6 GI supergroups' number of locations

    Here's how many locations five of the biggest gastroenterology-focused management service organizations have:
  • 6 GI supergroups by number of physicians

    Here are the number of physicians at five of the biggest gastroenterology-focused management service organizations: 
  • UCF-HCA Healthcare study identifies geographical links to colon cancer

    Raghav Bassi, MD, chief internal medicine resident at UCF-HCA Healthcare in Gainesville, Fla., has received honors for his research showing that southern U.S. states, which have the nation's highest obesity rates, also have the highest incidences of colon cancer. 
  • AGA issues guidance on weight loss drug usage prior to endoscopy

    The American Gastroenterological Association has issued new guidance for patients taking the popular diabetes and weight loss medications glucagon-like peptide 1 receptor agonists, known by brand names including Ozempic and Trulicity, prior to endoscopy. 
  • Gastroenterology Associates shutters 1 of 4 in-house labs

    Greenville, S.C.-based Gastroenterology Associates closed the GI lab at its Simpsonville, S.C.-based facility on Nov. 1. 
  • Southern Gastroenterology Associates opens 2nd location

    Southern Gastroenterology Associates has opened its second location in South Boston, Va., according to a Nov. 6 report from The Gazette-Virginian.
  • Claritas HealthTech establishes spinoff for AI-assisted GI solutions

    Medical image enhancement and AI diagnostic software solutions company Claritas HealthTech has established a U.S.-based spinoff, Intelligent Scopes Corp., that will focus on the research, development and delivery of endoscopic image processing and AI-assisted diagnostic solutions for urology and gastroenterology.
  • How AI is changing gastroenterology for the better

    On Oct. 23, Iterative Health released research findings that demonstrated the effectiveness of artificial intelligence for use in the treatment and management of inflammatory bowel disease and in improving adenoma detection during colonoscopies. 
  • Corewell Health adds Great Lakes Gastroenterology to network

    Grand Rapids, Mich.-based Corewell Health added Great Lakes Gastroenterology in St. Joseph, Mich., to its network on Nov. 1, Benton-Michiana Spirit News reported Nov. 2.
  • UnitedHealthcare adds 1st digital GI treatment partner

    UnitedHealthcare has formed a partnership with Vivante Health, adding GIThrive and its digital gastrointestinal care services to its member offerings. 
  • District court dismisses GI lawsuit against the FDA

    The U.S. District Court for the District of Columbia has denied a request from Norwich Pharmaceuticals that would require the FDA to grant immediate final approval of its new drug application for its gastrointestinal medication Xifaxan. 
  • 7 health systems seeking GI leaders

    Here are seven health systems and hospitals that posted job listings seeking gastroenterology expertise in the last week: 
  • 7 gastroenterologists in the headlines

    Here are seven gastroenterologists who have made headlines, as reported by Becker's since Oct. 4: 
  • United Digestive physician completes 1st peroral endoscopic myotomy

    United Digestive physician Daniel Mullady, MD, a gastroenterology and interventional endoscopy specialist at the Center for Digestive and Liver Health in Savannah, Ga., has completed the first peroral endoscopic myotomy in the area. 
  • 3 forces disrupting gastroenterology

    Artificial intelligence, prior authorization and decreased reimbursements all have a big role in the future of gastroenterology. 

Featured Webinars

Featured Whitepapers

Featured Podcast

Top 40 Articles from the Past 6 Months